Literature DB >> 9375807

Inhibition of annexin V-dependent Ca2+ movement in large unilamellar vesicles by K201, a new 1,4-benzothiazepine derivative.

N Kaneko1, R Matsuda, M Toda, K Shimamoto.   

Abstract

Examination was made of the effect of annexin V on Ca2+ movement into large unilamellar vesicles (LUV) using fura-2, a calcium-sensitive fluorescent dye. To avoid the possible difficulties relating to the addition of annexin V and/or Ca2+ in fura-2-loaded LUV, the burst method was used. LUV, preincubated with rat annexin V in the presence of Ca2+, were collected by centrifugation and resuspended, and then burst with Triton X-100 in the presence of fura-2. Inward Ca2+ movement across the artificial lipid membrane was measured by determination of fura-2 fluorescence due to the leaked Ca2+ from ruptured LUV. The observed Ca2+ signal increased dependent on annexin V and Ca2+ concentrations, whereas bovine serum albumin did not affect this signal up to 1 microM. Thus, annexin V shows Ca2+ channel activity in LUV. K201, a novel 1,4-benzothiazepine, inhibited inward Ca2+ movement into LUV caused by annexin V in a dose-dependent manner. In the presence of 50 nM annexin V and 400 microM Ca2+, 3 microM K201 showed significant inhibition of Ca2+ movement due to annexin V, and 50% inhibition was achieved at 25 microM K201. On the other hand, diltiazem had no such effect even at 30 microM. K201 is thus shown to have inhibitory activity on inward Ca2+ movement due to annexin V in artificial vesicles and may prove useful as a probe for elucidating the functions of annexin V in vivo.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9375807     DOI: 10.1016/s0005-2736(97)00132-6

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  17 in total

1.  Inhibitory effects of JTV-519, a novel cardioprotective drug, on potassium currents and experimental atrial fibrillation in guinea-pig hearts.

Authors:  H Nakaya; Y Furusawa; T Ogura; M Tamagawa; H Uemura
Journal:  Br J Pharmacol       Date:  2000-12       Impact factor: 8.739

2.  Collagen/annexin V interactions regulate chondrocyte mineralization.

Authors:  Hyon Jong Kim; Thorsten Kirsch
Journal:  J Biol Chem       Date:  2008-02-14       Impact factor: 5.157

3.  The effect of K201 on isolated working rabbit heart mechanical function during pharmacologically induced Ca2+ overload.

Authors:  A Kelly; E B Elliott; R Matsuda; N Kaneko; G L Smith; C M Loughrey
Journal:  Br J Pharmacol       Date:  2012-02       Impact factor: 8.739

Review 4.  Calcium Signaling and Cardiac Arrhythmias.

Authors:  Andrew P Landstrom; Dobromir Dobrev; Xander H T Wehrens
Journal:  Circ Res       Date:  2017-06-09       Impact factor: 17.367

5.  Immunological development and cardiovascular function are normal in annexin VI null mutant mice.

Authors:  T E Hawkins; J Roes; D Rees; J Monkhouse; S E Moss
Journal:  Mol Cell Biol       Date:  1999-12       Impact factor: 4.272

6.  Treatment of catecholaminergic polymorphic ventricular tachycardia in mice using novel RyR2-modifying drugs.

Authors:  Na Li; Qiongling Wang; Martha Sibrian-Vazquez; Robert C Klipp; Julia O Reynolds; Tarah A Word; Larry Scott; Guy Salama; Robert M Strongin; Jonathan J Abramson; Xander H T Wehrens
Journal:  Int J Cardiol       Date:  2016-10-29       Impact factor: 4.164

7.  Urinary annexin V in children with nephrotic syndrome: a new prognostic marker?

Authors:  Behcet Simsek; Mithat Buyukcelik; Mustafa Soran; Aysun K Bayazit; Aytul Noyan; Gulsah Seydaoglu; Ali Anarat
Journal:  Pediatr Nephrol       Date:  2007-11-13       Impact factor: 3.714

8.  Effects of K-201 on the calcium pump and calcium release channel of rat skeletal muscle.

Authors:  Janos Almassy; Monika Sztretye; Balazs Lukacs; Beatrix Dienes; Laszlo Szabo; Peter Szentesi; Guy Vassort; Laszlo Csernoch; Istvan Jona
Journal:  Pflugers Arch       Date:  2008-05-06       Impact factor: 3.657

Review 9.  Calcium cycling proteins and heart failure: mechanisms and therapeutics.

Authors:  Andrew R Marks
Journal:  J Clin Invest       Date:  2013-01-02       Impact factor: 14.808

Review 10.  Pharmacological characteristics and clinical applications of K201.

Authors:  Noboru Kaneko; Ryuko Matsuda; Yoshihito Hata; Ken Shimamoto
Journal:  Curr Clin Pharmacol       Date:  2009-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.